<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03360045</url>
  </required_header>
  <id_info>
    <org_study_id>71146310-511.06-E.223856</org_study_id>
    <nct_id>NCT03360045</nct_id>
  </id_info>
  <brief_title>Comparing Effectiveness of Merocel and Packing With Tranexamic Acid in the Management of Anterior Epistaxis</brief_title>
  <official_title>The Evaluation of Effectiveness of Nasal Compression With Tranexamic Acid Compared to Simple Nasal Compression and Merocel Packing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kecioren Education and Training Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kecioren Education and Training Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this study is evaluate whether superior nasal compression with tranexamic acid to
      simple nasal compression and Merocel packing.

      In this study, patients who presented with non-traumatic anterior epistaxis to emergency
      departments will be included in this study. Three different therapy option are created;
      first, nasal compression with tranexamic acid, second, simple nasal compression without any
      drugs. And third, packing with Merocel.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2018</start_date>
  <completion_date type="Anticipated">August 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success rate of interventions to stop bleeding</measure>
    <time_frame>First 15 minutes</time_frame>
    <description>Percentages of numbers of patients who have stopped bleeding within first 15 minutes after nasal compression or Merocel packing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Numbers of patients who needs rescue treatment</measure>
    <time_frame>After 15 minutes first intervention method.</time_frame>
    <description>In patients who have unstoppable epistaxis within 15 minutes, Merocel packing will be applied as a rescue treatment. Numbers of these patients will be recorded.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Re-bleeding</measure>
    <time_frame>24 hour</time_frame>
    <description>Frequency of re-bleeding within first 24 hours.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Tranexamic Acid</condition>
  <condition>Epistaxis</condition>
  <condition>Nasal Packing</condition>
  <arm_group>
    <arm_group_label>Tranexamic acid group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>500mg tranexamic acid is sprayed in the nose by atomizer spray, and then is applied nasal compression by manually.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>5ml normal saline is sprayed in the nose by atomizer spray, and then is applied nasal compression by manually.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Merocel Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Merocel packing is applied.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranexamic Acid</intervention_name>
    <description>500mg tranexamic acid is sprayed in the nose by atomizer spray, and then is applied nasal compression by manually.</description>
    <arm_group_label>Tranexamic acid group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>5 cc normal saline is sprayed in the nose by atomizer spray, and then is applied nasal compression by manually.</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Merocel</intervention_name>
    <description>Merocel packing is applied.</description>
    <arm_group_label>Merocel Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with anterior epistaxis older than 18 year and accept to participate in the
             study

        Exclusion Criteria:

          -  Patients younger than 18 years

          -  Patients who used anticoagulation therapy

          -  Patients who have hemodynamically instability

          -  Traumatic epistaxis

          -  Patients who have known bleeding disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Şeref Kerem Çorbacıoğlu</last_name>
    <phone>05437656176</phone>
    <email>serefkeremcorbacioglu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sedat Akkan</last_name>
    <phone>05422126060</phone>
    <email>sedatakkan@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Keçiören Training and Research Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06000</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Şeref Kerem Çorbacıoğlu</last_name>
      <phone>05437656176</phone>
      <email>serefkeremcorbacioglu@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2017</study_first_submitted>
  <study_first_submitted_qc>November 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2017</study_first_posted>
  <last_update_submitted>April 5, 2018</last_update_submitted>
  <last_update_submitted_qc>April 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kecioren Education and Training Hospital</investigator_affiliation>
    <investigator_full_name>Şeref Kerem Çorbacıoğlu</investigator_full_name>
    <investigator_title>Associated professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epistaxis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
    <mesh_term>Polyvinyl alcohol formaldehyde foam</mesh_term>
    <mesh_term>Formaldehyde</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

